Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice.
Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the 'humanization' of murine monoclonal antibodies (mAbs) is a time-consuming and expensive process that has the inherent drawback of...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-10-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2949385?pdf=render |